Navigation Links
Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs
Date:11/4/2010

>Clinical trial data 143

Only Phase I results in solid tumors have been made available to date 143

SWOT analysis 144

Datamonitor drug assessment scorecard for ramucirumab 144

Clinical and commercial attractiveness 145

A lack of clinical trial data makes it difficult to judge ramucirumab's potential in gastric cancer 145

Ramucirumab will lose out to Afinitor in terms of first-to-market advantage for second-line gastric cancer 145

The failure of Avastin in the first-line setting may work in ramucirumab's favor 146

Eli Lilly's experience in the oncology market will prove crucial in ensuring ramucirumab's success in gastric cancer 146

Satisfaction of unmet needs 146

Forecasts to 2019 147

6. Hepatocellular Carcinoma 149

Key findings 149

Disease overview 149

Definition 149

Hepatitis is a known risk factor for hepatocellular carcinoma 149

Patient segmentation 150

Several staging systems exist for hepatocellular carcinoma 150

Epidemiology 151

Seven major markets 151

Rest of the world 152

Current treatment options 153

Current comparator therapy 155

Nexavar (sorafenib; Onyx Pharmaceuticals/Bayer Schering) 155

Unmet need in hepatocellular carcinoma 155

Better systemic therapy is required in all lines of treatment 156

Clinical trials are currently poorly designed 157

Target product profile versus current level of attainment 157

Pipeline analysis and forecasts 158

Pipeline summary 158

Comparative forecasts 160

Brivanib (BMS-582664; Bristol-Myers Squibb) 163

Drug overview 163

Drug profile 163

Key historical events 164

Clinical trial data 165

Phase II results show brivanib to confer activity in both the first- and second-line treatment settings for advanced hepatocellular carcinoma 165

SWOT analysis 166

Datamonitor drug
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Karyopharm Therapeutics Inc. Closes $20 Million Series A Financing to Advance Pipeline of Novel Nuclear Transport Modulators for Cancer, Inflammation and Other Disorders
2. Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs
3. Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2010 Financial Results
4. Reportlinker Adds Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline
5. Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports
6. Updated Pfizer Pipeline Focuses on Value, Unmet Medical Need
7. Reportlinker Adds Electrophysiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
8. Reportlinker Adds Prosthetic Heart Valves - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
9. Abbott to Present Data on Market-Leading XIENCE V® and Promising Vascular Pipeline at TCT 2010
10. Reportlinker Adds Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
11. Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Jan. 23, 2015  A new analysis of Centers for ... enrollment data shows that 81 percent of seniors chose ... extra discounts at certain pharmacies. The findings were released ... plans are now the foundation of Medicare Part D," ...
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, Inc. today ... Inc. for the compounding, packaging and distributing of its naltrexone ... the United States . KRS ... compounding naltrexone tablets in various strengths for individual patients in ...
(Date:1/23/2015)... 23, 2015  Now available for sale, The Armor1 Ankle ... prevents ankle sprains by cushioning the ankle from an ... around the outside of any shoe type and allows ... still offering protection against sprains. With customers in physical ...
Breaking Medicine Technology:New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2
... Holdings, Inc. (OTC Bulletin Board: ADLS ), announced ... discussing the Company,s 2010 third quarter financial results on Friday, ... Ph.D., Chairman & Chief Executive Officer, as well as other ... on the Company. A press release reporting the 2010 third ...
... 2010 Neuraltus Pharmaceuticals, a privately held biopharmaceutical ... that address critical unmet needs, primarily in the ... was awarded three grants totaling $733,437 ... (QTDP).  The grants are being provided under section ...
Cached Medicine Technology:Advanced Life Sciences to Host 2010 Third Quarter Financial Results Conference Call and Webcast 2Neuraltus Pharmaceuticals Awarded $733,437 Under the Qualifying Therapeutic Discovery Projects Grant Program (QTDP) 2Neuraltus Pharmaceuticals Awarded $733,437 Under the Qualifying Therapeutic Discovery Projects Grant Program (QTDP) 3
(Date:1/22/2015)... Gabe’s Chemo Duck Program is pleased to announce the release of ... kids with cancer. The Chemo Duck App, available on iTunes for ... games to help children of all ages living with cancer adjust ... kids entertained, educated and at ease while waiting for clinic visits ...
(Date:1/22/2015)... 2015 Blue Cross and Blue Shield of ... what it means to “Live Fearless.” , The ... share their stories about how they or someone they know ... by living in the moment. By telling these types of ...
(Date:1/22/2015)... 2015 Thousand of GranuFlo lawsuits ( ... its GranuFlo and NaturaLyte dialysis concentrates continue to move ... District Court, District of Massachusetts, Bernstein Liebhard LLP reports. ... has remanded a case filed by the state of ...
(Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 ... College of Sports Medicine flagship journal Medicine & ... with L-Citrulline before exercise may help reduce gastrointestinal ... exercise. 1 , Participants in the double-blind, ...
(Date:1/22/2015)... 2015 Payday lending practices in four ... cause financial distress to the states that permit them, ... University’s Center on Race and Wealth. , While they ... payday loans at the same time substantially depress economic ...
Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
... Beauty Broadcast Benefits the Breast Cancer Research Fund, ... to be,tickled pink this May when leading multimedia retailer ... 27 at 1 AM (ET) and 6 PM,(ET). These ... with a portion of the proceeds benefiting the Breast ...
... speech June 9 in Atlanta, DENVER, May 21 ... Disease Control and Prevention (CDC), will,discuss water professionals, role ... American Water Works Association,s Annual Conference,& Exposition (ACE08) at ... one of the leading public health experts in the ...
... HILL, N.C., May 21 In this ... increasingly,complex organizational and decision-making structures to effectively,represent ... it onto hospital,formularies., Best Practices, LLC,s ... Effectiveness" (available at, http://www.best-in-class.com/cr208.htm ) addresses ...
... in Three of the Last Four ... ... PER ) and Harvard Pilgrim Health Care were named by the,Outsourcing ... by the Everest Group and Forbes,magazine, these awards honor the most outstanding ...
... Two outstanding members of the Worcester Polytechnic Institute ... during the universitys 140th Commencement exercises on May 17, ... Donald K. Peterson 71, chair of the WPI Board ... Inc., the prize honors WPI faculty members for overall ...
... than those having kidney replacement alone , , WEDNESDAY, ... alone, a simultaneous kidney-pancreas transplant improves the likelihood of ... end-stage renal disease (ESRD), according to a German study. ... more than 11,000 patients with type 1 diabetes and ...
Cached Medicine News:Health News:A Touch of Pink Never Looked So Good 2Health News:CDC Director to Address Public Health and Drinking Water at ACE08 2Health News:Harvard Pilgrim Health Care and Perot Systems Named as 'Best Partnership' by Outsourcing Center 2Health News:Harvard Pilgrim Health Care and Perot Systems Named as 'Best Partnership' by Outsourcing Center 3Health News:Harvard Pilgrim Health Care and Perot Systems Named as 'Best Partnership' by Outsourcing Center 4Health News:Harvard Pilgrim Health Care and Perot Systems Named as 'Best Partnership' by Outsourcing Center 5Health News:Worcester Polytechnic Institute announces 2008 Chairman's Exemplary Faculty Prize winners 2Health News:Worcester Polytechnic Institute announces 2008 Chairman's Exemplary Faculty Prize winners 3Health News:Combo Kidney-Pancreas Transplant Boosts Survival in Diabetics 2
For the quantitative determination of total cholesterol in serum....
For the quantitative determination of total cholesterol in human serum....
Intended for the quantitative determination of total cholesterol in serum. Single vial, dry powder reagent. Reaction: Endpoint. Wavelength: 500 nm. Linearity: 700 mg/dL (12.9 mmol/L)....
For the quantitative in vitro determination of lithium in serum and plasma. Wavelength: 550 nm. Linear range: up to 4 mm....
Medicine Products: